Home › Markets › Health Care › APVO

Aptevo Therapeutics Inc. (APVO)

APVO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.73
-5.79% on the day
Market cap
$3.1M
Nano cap
Revenue
No annual revenue filed since the period ending 2022-12-31
Net income
No annual revenue filed since the period ending 2022-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerAPVO on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001671584
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue filed since the period ending 2022-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42026-09-03
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-10-14
Latest proxyDEF 14A2026-08-31

Source: SEC EDGAR submissions feed, 733 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RDHLRedhill Biopharma Ltd.$0.5150-3.45%$3.1M
CMNDClearmind Medicine Inc. Common Shares$6.23-4.74%$3.2M
SXTP60 Degrees Pharmaceuticals Inc.$0.9000-1.70%$3.2M
XRTXXORTX Therapeutics Inc. Common Shares$1.68-2.33%$3.1M
CAPSCapstone Holding Corp.$0.1242-6.83%$3.3M
DCOYDecoy Therapeutics Inc.$1.24-13.29%$3.0M
EOCNEocene Ltd.$3.17-1.71%$3.3M
ONCOOnconetix Inc.$0.5550-6.00%$2.9M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier